Jakob Mathiszig-Lee

Royal Marsden NHS Foundation Trust

Papers

1

Total Citations

17

H-Index

1

About

Dr. Jakob Mathiszig-Lee is a pioneering interventional radiologist whose work sits at the intersection of precision oncology and advanced image-guided therapy. His primary research focuses on the development and clinical validation of robotic and stereotactic guidance systems for minimally invasive cancer treatments, particularly radiofrequency ablation (RFA) of pulmonary metastases. His landmark 2023 comparative cohort study, which has already garnered 17 citations, demonstrated that robotic-assisted CT-guided RFA significantly reduces procedural time and needle manipulation compared to traditional freehand techniques, while maintaining comparable safety and efficacy. This work directly addresses a critical bottleneck in lung ablation—the challenge of precise electrode placement in a moving, ventilated organ—and provides compelling evidence for the adoption of robotic platforms in thoracic interventions. By systematically quantifying the advantages of robotic guidance over conventional methods, Mathiszig-Lee has helped establish a new standard for procedural efficiency and reproducibility in interventional oncology. His contributions are particularly notable for bridging the gap between established robotic applications in liver ablation and the more technically demanding pulmonary setting, offering patients with oligometastatic lung disease a more streamlined, potentially curative treatment pathway.

Research Focus

Key Achievements

1
H-Index
1
Papers
17
Total Citations
17
Avg Citations/Paper
🏆 Most Cited Paper
Robotic versus freehand CT-guided radiofrequency ablation of pulmonary metastases: a comparative cohort study
17 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 10
🏛 Institutions: Royal Marsden NHS Foundation Trust

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago